Objective: To assess whether
apolipoprotein E-containing HDL-C (
APOE-HDL-C) is causally associated with
coronary heart disease (CHD) risk. Methods: In total, 5 417
cardiovascular disease-free participants at baseline were followed up for up to 10 years in the Chinese Multi-provincial Cohort Study.
APOE-HDL-C and HDL-C were measured in all participants.
APOE-HDL-C/total HDL-C ratio was calculated. Multivariate Cox regression was employed to assess the association between HDL-C related
biomarkers and 10-year CHD incident risk. Results: A total of 100 incident CHD events occurred during a mean 6.8 years follow-up. High levels of baseline HDL-C related
biomarkers were significantly negatively associated with incident CHD risk. Comparison with participant with lowest level of
APOE-HDL-C/total HDL-C ratio, those with highest level of
APOE-HDL-C/total HDL-C ratio had 74% decreased risk of CHD (HR=0.26, 95%CI: 0.12-0.71). The individual with the highest level of
APOE-HDL-C/total HDL-C ratio had the lowest absolute risk[0.48% (0.44%-0.52%)] of CHD, which was significantly lower than that [0.83% (0.78%-0.88%)] of the individual with the highest level of HDL-C. Conclusions: Our findings revealed that the
APOE-HDL-C/total HDL-C ratio was significantly related to a 10-year increased risk of incident CHD, even beyond HDL-C. It seemed that
APOE-HDL-C could serve as a new
indicator of the anti-atherosclerotic function of HDL.